Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging Molecular Targets for Treatment of Nonalcoholic Fatty Liver Disease
Ze Chen, Yao Yu, Jingjing Cai, et al.
Trends in Endocrinology and Metabolism (2019) Vol. 30, Iss. 12, pp. 903-914
Closed Access | Times Cited: 105

Showing 1-25 of 105 citing articles:

Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease
Ze Chen, Ruifeng Tian, Zhi‐Gang She, et al.
Free Radical Biology and Medicine (2020) Vol. 152, pp. 116-141
Open Access | Times Cited: 935
Nonalcoholic Fatty Liver Disease
Yan-Ci Zhao, Guojun Zhao, Ze Chen, et al.
Hypertension (2019) Vol. 75, Iss. 2, pp. 275-284
Open Access | Times Cited: 188
Nonalcoholic Fatty Liver Disease Pandemic Fuels the Upsurge in Cardiovascular Diseases
Jingjing Cai, Xiaojing Zhang, Yan‐Xiao Ji, et al.
Circulation Research (2020) Vol. 126, Iss. 5, pp. 679-704
Open Access | Times Cited: 151
Mechanisms of Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome. A Narrative Review
Luca Rinaldi, Pia Clara Pafundi, Raffaele Galiero, et al.
Antioxidants (2021) Vol. 10, Iss. 2, pp. 270-270
Open Access | Times Cited: 137
Liver Steatosis, Gut-Liver Axis, Microbiome and Environmental Factors. A Never-Ending Bidirectional Cross-Talk
Agostino Di Ciaula, Jacek Baj, Gabriella Garruti, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 8, pp. 2648-2648
Open Access | Times Cited: 126
Nonalcoholic Fatty Liver Disease (NAFLD). Mitochondria as Players and Targets of Therapies?
Agostino Di Ciaula, Salvatore Passarella, Harshitha Shanmugam, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5375-5375
Open Access | Times Cited: 92
Role of Oxidative Stress in Hepatic and Extrahepatic Dysfunctions during Nonalcoholic Fatty Liver Disease (NAFLD)
Andrea González, Camila Huerta-Salgado, Josué Orozco-Aguilar, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-16
Open Access | Times Cited: 84
TNFAIP3 Interacting Protein 3 Overexpression Suppresses Nonalcoholic Steatohepatitis by Blocking TAK1 Activation
Dan Liu, Peng Zhang, Junjie Zhou, et al.
Cell Metabolism (2020) Vol. 31, Iss. 4, pp. 726-740.e8
Open Access | Times Cited: 81
Nonalcoholic Fatty Liver Disease: An Emerging Driver of Cardiac Arrhythmia
Ze Chen, Jiayi Liu, Feng Zhou, et al.
Circulation Research (2021) Vol. 128, Iss. 11, pp. 1747-1765
Open Access | Times Cited: 76
Tripartite motif 16 ameliorates nonalcoholic steatohepatitis by promoting the degradation of phospho-TAK1
Lin Wang, Xin Zhang, Zhibin Lin, et al.
Cell Metabolism (2021) Vol. 33, Iss. 7, pp. 1372-1388.e7
Open Access | Times Cited: 71
The multi-faces of Angptl8 in health and disease: Novel functions beyond lipoprotein lipase modulation
Mohamed Abu‐Farha, Anindya Ghosh, Irina Al‐Khairi, et al.
Progress in Lipid Research (2020) Vol. 80, pp. 101067-101067
Open Access | Times Cited: 70
Perspectives on Precision Medicine Approaches to NAFLD Diagnosis and Management
Amedeo Lonardo, Juan Pablo Arab, Marco Arrese
Advances in Therapy (2021) Vol. 38, Iss. 5, pp. 2130-2158
Open Access | Times Cited: 67
DRAK2 aggravates nonalcoholic fatty liver disease progression through SRSF6-associated RNA alternative splicing
Yufeng Li, Jun‐Yu Xu, Yuting Lu, et al.
Cell Metabolism (2021) Vol. 33, Iss. 10, pp. 2004-2020.e9
Open Access | Times Cited: 62
Hepatocyte Mitochondrial Dynamics and Bioenergetics in Obesity-Related Non-Alcoholic Fatty Liver Disease
Aigli‐Ioanna Legaki, Ioannis I. Moustakas, Michalina Sikorska, et al.
Current Obesity Reports (2022) Vol. 11, Iss. 3, pp. 126-143
Open Access | Times Cited: 55
Investigating the Link between Ketogenic Diet, NAFLD, Mitochondria, and Oxidative Stress: A Narrative Review
Antonio Paoli, Giuseppe Cerullo
Antioxidants (2023) Vol. 12, Iss. 5, pp. 1065-1065
Open Access | Times Cited: 41
NAFLD, MAFLD, and beyond: one or several acronyms for better comprehension and patient care
Piero Portincasa
Internal and Emergency Medicine (2023) Vol. 18, Iss. 4, pp. 993-1006
Open Access | Times Cited: 26
Non-alcoholic fatty liver disease promotes liver metastasis of colorectal cancer via fatty acid synthase dependent EGFR palmitoylation
Chi Zhang, Yue Zhang, Yan Dong, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 9
Association between composite dietary antioxidant index and metabolic dysfunction associated steatotic liver disease: result from NHANES, 2017-2020
Zhaofu Zhang, Hao Wang, Youpeng Chen
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 9
An Endoplasmic Reticulum Stress–MicroRNA‐26a Feedback Circuit in NAFLD
Haixia Xu, Yan Tian, Dongmei Tang, et al.
Hepatology (2020) Vol. 73, Iss. 4, pp. 1327-1345
Closed Access | Times Cited: 61
Immunity as Cornerstone of Non-Alcoholic Fatty Liver Disease: The Contribution of Oxidative Stress in the Disease Progression
Marcello Dallio, Moris Sangineto, Mario Romeo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 1, pp. 436-436
Open Access | Times Cited: 55
Nonalcoholic Fatty Liver Disease and Cardiac Remodeling Risk: Pathophysiological Mechanisms and Clinical Implications
Jianghua Zhou, Lan Bai, Xiaojing Zhang, et al.
Hepatology (2021) Vol. 74, Iss. 5, pp. 2839-2847
Closed Access | Times Cited: 55
Ramulus Mori (Sangzhi) Alkaloids Alleviate High-Fat Diet-Induced Obesity and Nonalcoholic Fatty Liver Disease in Mice
Yanmin Chen, Chunfang Lian, Qian-Wen Sun, et al.
Antioxidants (2022) Vol. 11, Iss. 5, pp. 905-905
Open Access | Times Cited: 34
Ferulic Acid Prevents Nonalcoholic Fatty Liver Disease by Promoting Fatty Acid Oxidation and Energy Expenditure in C57BL/6 Mice Fed a High-Fat Diet
Zhixin Luo, Mengqian Li, Qiong Yang, et al.
Nutrients (2022) Vol. 14, Iss. 12, pp. 2530-2530
Open Access | Times Cited: 34
Energy substrate metabolism and oxidative stress in metabolic cardiomyopathy
Ze Chen, Zhaoxia Jin, Jingjing Cai, et al.
Journal of Molecular Medicine (2022) Vol. 100, Iss. 12, pp. 1721-1739
Closed Access | Times Cited: 30
Hrd1-mediated ACLY ubiquitination alleviate NAFLD in db/db mice
Kai Li, Kaini Zhang, Wang Hai, et al.
Metabolism (2020) Vol. 114, pp. 154349-154349
Closed Access | Times Cited: 49
Page 1 - Next Page

Scroll to top